Chien Fu Chen
Fortuna: 776 532 $ al 31/07/2026
Fortuna: 776 532 $ al 31/07/2026
Chien Fu Chen is currently a Director at Taiwan Styrene Monomer Corp.
and Adimmune Corp.
He was formerly a Director at Enimmune Corp.
Chen holds an MBA from Peking University and an undergraduate degree from the University of California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ENIMMUNE CORPORATION 2,23 % | 30/09/2025 | 1.608.760 ( 2,23 % ) | 776 532 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADIMMUNE CORPORATION | Director/Miembro de la Junta | 29/06/2017 |
| TAIWAN STYRENE MONOMER CORPORATION | Director/Miembro de la Junta | 31/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| ENIMMUNE CORPORATION | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Taiwan Styrene Monomer Corp.
Taiwan Styrene Monomer Corp. Chemicals: SpecialtyProcess Industries Manufactures styrene monomer, para-diethyl benzene, toluene and ethyl benzene | Process Industries |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adimmune Corp.
Adimmune Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures influenza vaccine | Health Technology |
Enimmune Corp.
Enimmune Corp. BiotechnologyHealth Technology Develops vaccine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.